Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Research on hair disorders has advanced, with promising future progress in understanding and treating these conditions.

The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Intralesional triamcinolone acetonide is the most effective treatment for localized alopecia areata.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Malondialdehyde-modified DNA may trigger an immune response in alopecia areata patients.

These specific gene polymorphisms are not linked to Alopecia Areata in Egyptians.

Many children with alopecia areata also have other autoimmune diseases.

Cross-section trichometry is an accurate method to measure hair loss and growth.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

PGD2 stops hair growth and is higher in bald men with AGA.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Topical JAK inhibitors may help treat alopecia universalis by promoting hair regrowth.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Late-onset alopecia areata in Taiwanese patients is more common in women, usually starts at age 57, often involves less than 10% hair loss, and may have a minimal link to thyroid issues.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

Effective treatments for severe alopecia areata are still lacking.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Microneedling helped two Pomeranian dogs with a hair growth disorder grow back 90% of their fur in 12 weeks, and the results lasted for a year.

The AIRE gene variant rs2075876 is linked to a higher risk of alopecia areata in males.

Two young siblings experienced hair loss without hormone issues or other skin problems.